perioperative immunotherapy(1) adverse event(1) non‐small cell lung cancer(1) PD‐1/PD‐L1 inhibitors(1) treatment discontinuation(1) infections(1) Immune checkpoint inhibitor(1) clinical recommendation(1) immune‐related adverse events(1) combination therapy(1) irAE(1) immune checkpoint(1) overall survival(1)